ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Thalia Therapeutics raised €3.1 million and acquired Sanmirna, a US firm. The fundraise backed the acquisition. The company is expanding its footprint through the deal.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
ChemT Biotechnology Raises $4M in Seed Funding